Operating Expenses Summary of Faes Farma, S.A.

Faes Farma, S.A.'s latest annual operating expenses in 2023 was 127.02 Million EUR , up 7.67% from previous year.
Faes Farma, S.A.'s latest quarterly operating expenses in 2024 Q2 was 50.66 Million EUR , down -52.19% from previous quarter.
Faes Farma, S.A. reported a annual operating expenses of 179.58 Million EUR in annual operating expenses 2022, up 16.97% from previous year.
Faes Farma, S.A. reported a annual operating expenses of 153.53 Million EUR in annual operating expenses 2021, up 4.25% from previous year.
Faes Farma, S.A. reported a quarterly operating expenses of 61.18 Million EUR for 2024 Q1, up 27.12% from previous quarter.
Faes Farma, S.A. reported a quarterly operating expenses of 193.37 Million EUR for 2023 FY, up 7.67% from previous quarter.

Annual Operating Expenses Chart of Faes Farma, S.A. (2023 - 2003)

Historical Annual Operating Expenses of Faes Farma, S.A. (2023 - 2003)

Year	Operating Expenses	Operating Expenses Growth
2023	127.02 Million EUR	7.67%
2022	179.58 Million EUR	16.97%
2021	153.53 Million EUR	4.25%
2020	147.26 Million EUR	-0.48%
2019	147.97 Million EUR	4.52%
2018	141.57 Million EUR	11.12%
2017	127.4 Million EUR	23.75%
2016	102.95 Million EUR	11.83%
2015	92.06 Million EUR	2.65%
2014	89.68 Million EUR	4.86%
2013	85.53 Million EUR	-4.68%
2012	89.72 Million EUR	-11.2%
2011	101.04 Million EUR	5.23%
2010	96.02 Million EUR	54.04%
2009	62.33 Million EUR	67.76%
2008	37.15 Million EUR	41.16%
2007	26.32 Million EUR	-27.19%
2006	36.15 Million EUR	-3.73%
2005	37.55 Million EUR	16.99%
2004	32.1 Million EUR	1.71%
2003	31.56 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	50.66 Million EUR	-52.19%
2024 Q1	61.18 Million EUR	27.12%
2023 FY	193.37 Million EUR	7.67%
2023 Q3	47.75 Million EUR	26.4%
2023 Q4	48.13 Million EUR	0.79%
2023 Q1	58.36 Million EUR	75.91%
2023 Q2	37.78 Million EUR	-35.27%
2022 Q2	36.83 Million EUR	-28.92%
2022 Q3	57.74 Million EUR	56.76%
2022 Q4	33.17 Million EUR	-42.54%
2022 Q1	51.82 Million EUR	142.3%
2022 FY	179.58 Million EUR	16.97%
2021 Q2	24.73 Million EUR	-45.8%
2021 FY	153.53 Million EUR	4.25%
2021 Q4	21.38 Million EUR	-65.38%
2021 Q3	61.77 Million EUR	149.8%
2021 Q1	45.63 Million EUR	258.36%
2020 FY	147.26 Million EUR	-0.48%
2020 Q1	50.16 Million EUR	165.41%
2020 Q2	19.89 Million EUR	-60.33%
2020 Q3	64.47 Million EUR	224.02%
2020 Q4	12.73 Million EUR	-80.25%
2019 Q3	56.93 Million EUR	85.7%
2019 Q2	30.65 Million EUR	-26.09%
2019 FY	147.97 Million EUR	4.52%
2019 Q1	41.47 Million EUR	6.97%
2019 Q4	18.9 Million EUR	-66.8%
2018 Q2	35.9 Million EUR	-1.37%
2018 Q4	38.77 Million EUR	27.14%
2018 FY	141.57 Million EUR	11.12%
2018 Q1	36.4 Million EUR	1.37%
2018 Q3	30.49 Million EUR	-15.06%
2017 Q3	28.76 Million EUR	-14.48%
2017 FY	127.4 Million EUR	23.75%
2017 Q1	29.1 Million EUR	22.48%
2017 Q4	35.9 Million EUR	24.83%
2017 Q2	33.63 Million EUR	15.58%
2016 FY	102.95 Million EUR	11.83%
2016 Q4	23.75 Million EUR	-7.97%
2016 Q3	25.81 Million EUR	-3.25%
2016 Q2	26.68 Million EUR	-0.06%
2016 Q1	26.7 Million EUR	63.96%
2015 Q2	25.56 Million EUR	-0.91%
2015 Q3	24.41 Million EUR	-4.49%
2015 Q4	16.28 Million EUR	-33.31%
2015 FY	92.06 Million EUR	2.65%
2015 Q1	25.8 Million EUR	171.35%
2014 Q3	30.27 Million EUR	29.76%
2014 Q4	9.5 Million EUR	-68.59%
2014 Q2	23.32 Million EUR	-12.24%
2014 FY	89.68 Million EUR	4.86%
2014 Q1	26.58 Million EUR	759.46%
2013 Q2	23.94 Million EUR	-9.9%
2013 Q3	31.91 Million EUR	33.3%
2013 Q4	3.09 Million EUR	-90.31%
2013 FY	85.53 Million EUR	-4.68%
2013 Q1	26.57 Million EUR	170.37%
2012 Q1	42.72 Million EUR	201.18%
2012 Q3	77.24 Million EUR	926.54%
2012 FY	89.72 Million EUR	-11.2%
2012 Q4	-37.76 Million EUR	-148.89%
2012 Q2	7.52 Million EUR	-82.39%
2011 Q1	47.54 Million EUR	0.0%
2011 Q4	-42.22 Million EUR	-145.45%
2011 Q3	92.89 Million EUR	3187.3%
2011 FY	101.04 Million EUR	5.23%
2011 Q2	2.82 Million EUR	-94.06%
2010 Q1	43.3 Million EUR	0.0%
2010 FY	96.02 Million EUR	54.04%
2010 Q2	5.79 Million EUR	-86.61%
2009 FY	62.33 Million EUR	67.76%
2008 FY	37.15 Million EUR	41.16%
2007 FY	26.32 Million EUR	-27.19%
2006 FY	36.15 Million EUR	-3.73%
2005 FY	37.55 Million EUR	16.99%
2004 FY	32.1 Million EUR	1.71%
2003 FY	31.56 Million EUR	0.0%

Peer Operating Expenses Comparison of Faes Farma, S.A.

Name	Operating Expenses	Operating Expenses Difference
Almirall, S.A.	668.75 Million EUR	81.005%
Laboratorio Reig Jofre, S.A.	73.18 Million EUR	-73.576%

Global Stocks Search

Faes Farma, S.A. (FAE.MC)

Operating Expenses Summary of Faes Farma, S.A.

Annual Operating Expenses Chart of Faes Farma, S.A. (2023 - 2003)

Historical Annual Operating Expenses of Faes Farma, S.A. (2023 - 2003)

Peer Operating Expenses Comparison of Faes Farma, S.A.